References
- Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33(7): 1040–7
- Celedon JC, Mathur-Wagh U, Fox J, et al. Systemic strongyloidiasis in patients infected with the human immunodeficiency virus: a report of 3 cases and review of the literature. Medicine (Baltimore) 1994;73(5): 256–63
- Phelps KR, Ginsberg SS, Cunningham AW, et al. Case report: adult T- cell leukemia/lymphoma associated with recurrent strongyloides hyperinfection. Am J Med Sci 1991;302(4): 224–8
- Torres JR, Isturiz R, Murillo J, et al. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis 1993;17(5): 900–2
- Dykstra MA, Friedman L, Murphy JW. Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect Immun 1977; 16(1): 129–35
- Spitzer ED, Spitzer SG, Freundlich LF, et al. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993; 341(8845): 595–6
- Houk VN, Moser KM. Pulmonary cryptococcosis: Must all receive amphotericin B? Ann Intern Med 1965;63(4): 583–96
- McDonnell JM, Hutchins GM. Pulmonary cryptococcosis. Hum Pathol 1985;16(2): 121–8
- Hammerman KJ, Powell KE, Christianson CS, et al. Pulmonary cryptococcosis: clinical forms and treatment. A Centers for Disease Control cooperative mycoses study. Am Rev Respir Dis 1973; 108(5): 1116–23
- Gal AA, Koss MN, Hawkins J, et al. The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1986;110(6): 502–7
- Fisher BD, Armstrong D. Cryptococcal interstitial pneumonia: value of antigen determination. N Engl J Med 1977;297(26): 1440–1
- Perfect JR, Durack DT, Gallis HA. Cryptococcemia. Medicine (Baltimore) 1983;62(2): 98–109
- Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981;94(5): 611–6
- Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30(4): 710–8
- National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996;24(5): 380–8
- Schening O, Lutwick LI, Chapnick EK. Pseudomonas aeruginosa infections: a late complication of AIDS with a need for consideration of secondary prophylaxis. Infect Med 1996;13(2):110–3,151
- Mendelson MH, Gurtman A, Szabo S, et al. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis 1994;18(6): 886–95
- Kielhofner M, Atmar RL, Hamill RJ, et al. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992; 14(2): 403–11
- Gremillion DH, Crawford GE. Measles pneumonia in young adults: an analysis of 106 cases. Am J Med 1981;71(4): 539–42
- Gray MM, Hann IM, Glass S, et al. Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centres: a retrospective review. Br Med J (Clin Res Ed) 1987;295(6589): 19–22
- Kaplan LJ, Daum RS, Smaron M, et al. Severe measles in immunocompromised patients. JAMA. 1992;267(9): 1237–41
- Siegel MM, Walter TK, Ablin AR. Measles pneumonia in childhood leukemia. Pediatrics 1977;60(1): 38–40
- Ross LA, Kim KS, Mason WH Jr, et al. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med 1990;88(3): 313–4